AptarGroup Inc
ATR: XNYS (USA)
Morningstar Rating for Stocks | Fair Value | Economic Moat | Capital Allocation |
---|---|---|---|
$934.00 | Rdcpn | Kgzxzhljn |
Aptar Reports Flat Growth; We Maintain $132 Fair Value Estimate and See Shares as Undervalued
Aptar reported decent third-quarter results driven by its pharmaceutical segment and pricing initiatives offsetting rising costs. Although we adjusted our near-term assumptions to account for lower-than-expected growth in the beauty and home and food and beverage segments, we are maintaining our $132 fair value estimate. The shares appear undervalued.